Skip to main content
ILLUMINA, INC. logo

ILLUMINA, INC. — Investor Relations & Filings

Ticker · ILMN ISIN · US4523271090 LEI · SQ95QG8SR5Q56LSNF682 US Manufacturing
Open in API
Filings indexed 2,572 across all filing types
Latest filing 2019-08-05 Director's Dealing
Country US United States of America
Listing US ILMN

About ILLUMINA, INC.

https://www.illumina.com

Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company is a provider of DNA sequencing and array-based technologies. Its portfolio includes next-generation sequencing (NGS) platforms, microarrays, library preparation kits, and bioinformatics software. These products and services are utilized by researchers and clinicians for applications in life science research, translational and consumer genomics, molecular diagnostics, oncology, and reproductive health. The company's solutions are designed to advance genomic discoveries and enable precision medicine by providing tools for DNA, RNA, and protein analysis.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2019-08-05 English
PRIMARY DOCUMENT
Director's Dealing
2019-07-31 English
10-Q
Interim / Quarterly Report Q2 2019
2019-07-31 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated July 29, 2019, reporting the issuance of a press release announcing financial results for the second quarter ended June 30, 2019. The text explicitly states that the press release is attached as Exhibit 99.1 and that the information is furnished under Item 2.02 Results of Operations and Financial Condition. The document itself does not contain detailed financial statements or substantive financial data but rather announces the release of the earnings information. The length of the document is 3898 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this filing is best classified as an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only.
2019-07-29 English
PRIMARY DOCUMENT
Director's Dealing
2019-07-25 English
PRIMARY DOCUMENT
Director's Dealing
2019-07-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.